COSM vs STEK
Cosmos Health Inc. and Stemtech Corporation, side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COSM | STEK |
|---|---|---|
| Revenue | $65.3M | $2.9M |
| Net income | $-19.1M | $-4.0M |
| Gross margin | 12.1% | 80.3% |
| Net margin | −29.3% | −140.7% |
| Return on equity | −89.1% | — |
| Diluted EPS | −$0.63 | −$0.02 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $-8.5M | $-483,583 |
| Equity | $18.4M | $-7.0M |
| Net debt / equity | 0.17× | — |
| Current ratio | 1.00× | 0.04× |
| Revenue CAGR 5y | 3.3% | −8.1% |
| Profit CAGR 5y | — | — |
COSM bills 22.7× the revenue of STEK, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
6 years side by side
| Fiscal year | COSM | STEK |
|---|---|---|
| FY2025 | $65.3M | $2.9M |
| FY2024 | $54.4M | $5.1M |
| FY2023 | $53.4M | $4.9M |
| FY2022 | $50.3M | $4.6M |
| FY2021 | $56.2M | $4.3M |
| FY2020 | $55.4M | $4.4M |
Net income by year
Bottom line
| Fiscal year | COSM | STEK |
|---|---|---|
| FY2025 | $-19.1M | $-4.0M |
| FY2024 | $-16.2M | $-3.8M |
| FY2023 | $-18.5M | $-5.4M |
| FY2022 | $-13.8M | $-8.5M |
| FY2021 | $-8.0M | $-7.1M |
| FY2020 | $820,786 | $-916,697 |
Advertisement
AdSense · Rectangle 336×280